Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly

In the previous study, revaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in a total of 161 elderly subjects (≥70 years of age) who had received the initial vaccination at least 5 years before (range: 5 to11 years) showed an acceptable safety profile and induction of immune re...

詳細記述

書誌詳細

出版年:	Human Vaccines & Immunotherapeutics
主要な著者:	Kenji Kawakami, Hiroyuki Kishino, Shinichi Kanazu, Kenichi Takahashi, Tomoharu Iino, Miyuki Sawata, Luwy Musey
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2018-08-01
主題:	23-valent pneumococcal polysaccharide vaccine revaccination time interval immunogenicity
オンライン･アクセス:	http://dx.doi.org/10.1080/21645515.2018.1456611